Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:461432-26-8
Molecular Formula:C21H25ClO6
Alias
More Information
[14C]-Dapagliflozin; (2S,3R,4R,5S,6R)-2-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-6-(Hydroxymethyl)Oxane-3,4,5-Triol; D-Glucitol,1,5-Anhydro-1-C-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-,(1S); Dapaglifozin; (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-Ethoxybenzyl)Phenyl]-6-(Hydroxymethy)Tetrahydro-2H-Pyran-3,4,5-Triol; Forxiga (Tn); (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-Ethoxybenzyl)Phenyl]-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-3,4,5-Triol
Brief Introduction
Dagglitazin is a sodium glucose cotransporter 2 inhibitor (sglt2i), which is a new oral hypoglycemic drug. It can inhibit SGLT2 activity, inhibit sodium glucose reabsorption in proximal renal tubules, promote urinary glucose excretion, and reduce blood glucose concentration.
Suppliers
View More Vendors (4） >
CAS:223673-61-8
Molecular Formula:C21H24N4O2S
Alias
More Information
N-(4-(2-(2-Hydroxy-2-Phenylethylamino)Ethyl)Phenyl)-2-(2-Aminothiazol-4-Yl)Acetamide; Ym-178; Mirabeqron; 2-Amino-N-[4-[2-[[(2R)-2-Hydroxy-2-Phenyl-Ethyl]Amino]-Ethyl]Phenyl]-4-Thiazoleacetamide; 2-(2-Amino-1,3-Thiazol-4-Yl)-N-(4-{2-[(2-Hydroxy-2-Phenylethyl)Amino]Ethyl}Phenyl)Acetamide; 4-Thiazoleacetamide, 2-Amino-N-(4-(2-(((2R)-2-Hydroxy-2-Phenylethyl)Amino)Ethyl)Phenyl)-
Brief Introduction
Mirabelon tablets, developed by Estelle pharmaceutical company of Japan, were listed in Japan on September 16, 2011 and approved by the US Food and Drug Administration (FDA) on June 28, 2012 for the treatment of adult overactive bladder (OAB). Mirabelon was the first to be used to treat overactive bladder β 3. Adrenoceptor agonists, whose successful marketing fills the gap β There is a blank of adrenoceptor agonists in the treatment of overactive bladder.
Suppliers
View More Vendors (4） >
CAS:171599-83-0
Molecular Formula:C28H38N6O11S
Alias
More Information
Sildenafil Citrate Salt; 5-[2-Ethoxy-5-(4-Methylpiperazin-1-Yl)Sulfonylphenyl]-1-Methyl-3-Propyl-4H-Pyrazolo[4,3-D]Pyrimidin-7-One,2-Hydroxypropane-1,2,3-Tricarboxylic Acid; Viagra,Revatio; Viagra, Sildenafil Citrate; 1-[[3-(4,7-Dihydro-1-Methyl-7-Oxo-3-Propyl-1H-Pyrazolo[4,3-D]Pyrimidin-5-Yl)-4-Ethoxyphenyl]Sulfonyl]-4-Methylpiperazine Citrate Salt; 5-[2-Ethoxy-5-(4-Methylpiperazin-1-Yl)Sulfonylphenyl]-1-Methyl-3-Propyl-4H-Pyrazolo[5,4-E]Pyrimidin-7-One Citrate Salt; 1-[[3-(6,7-Dihydro-1-Methyl-7-Oxo-3-Propyl-1H-Pyrazolo[4,3-D]Pyrimidin-5-Yl)-4-Ethoxyphenyl]Sulfonyl]-4-Methylpiperazine, 2-Hydroxy-1,2,3-Propanetricarboxylate; 5-[2-Ethoxy-5-[(4-Methyl-Piperazin-1-Yl)Sulfonyl]Phenyl]-1,6-Dihydro-1-Methyl-3-Propyl-7H-Pyrazolo[4,3-D]Pyrimidin-7-One Citrate
Brief Introduction
Sildenafil citrate, a selective 5-phosphodiesterase inhibitor, enhances nitric oxide dependent pulmonary vasodilation mediated by cyclic guanosine monophosphate by inhibiting the decomposition of cyclic guanosine monophosphate. In addition to direct dilation of pulmonary vessels, it can also prevent or reverse vascular remodeling. It is used for impotence patients with erectile dysfunction.
Suppliers
View More Vendors (3） >
Yugant Chemicals
For erectile dysfunction
/
-
CAS:832720-36-2
Molecular Formula:C32H29F5N3NaO5
Alias
More Information
Sodium,4-[[(1R)-2-[5-(2-Fluoro-3-Methoxyphenyl)-3-[[2-Fluoro-6-(Trifluoromethyl)Phenyl]Methyl]-4-Methyl-2,6-Dioxopyrimidin-1-yl]-1-Phenylethyl]Amino]Butanoate; Elagolix Sodium salt; UNII-5948VUI423; Elagolix Sodium [USAN]; Flagolix Sodium; NBI 56418NA
Brief Introduction
Oxagolide sodium can be used as an organic synthesis intermediate and pharmaceutical intermediate. It is mainly used in laboratory research and development process and chemical and pharmaceutical synthesis process.
Suppliers
View More Vendors (3） >
CAS:737789-87-6
Molecular Formula:C29H29F2N7O5S
Alias
More Information
1-(4-(1-(2,6-Difluorobenzyl)-5-((Dimethylamino)Methyl)-3-(6-Methoxypyridazin-3-yl)-2,4-Dioxo-1,2,3,4-Tetrahydrothieno[2,3-d]Pyrimidin-6-yl)Phenyl)-3-Methoxyurea; TAK-385
Brief Introduction
Relugolix is an oral gonadotropin releasing hormone receptor antagonist
Suppliers
View More Vendors (3） >
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!